Micronase and aortic valve sclerosis Patient Reports February 12, 2012

Micronase Side Effects Report #4583639-2
Micronase side effect was reported by a Physician from on Jan 31, 2005. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase. After drug was administered, patient experienced the following side effects: acute myocardial infarction, aortic valve incompetence, aortic valve sclerosis, blood pressure increased, cardiac failure congestive, cardiomegaly, carotid artery stenosis, contrast media reaction, coronary artery disease . Micronase dosage: 15 MG (15 MG, DAILY), ORAL. During the same period patient was treated with SIMVASTATIN, QUINAPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE, CETIRIZINE, CANDESARTAN CILEXETIL, FEXOFENADINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Micronase Side Effects Report #4592547-2
Micronase side effect was reported by a Physician from on Feb 16, 2005. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase. After drug was administered, patient experienced the following side effects: acute myocardial infarction, aortic aneurysm , aortic valve incompetence, aortic valve sclerosis, cardiac failure congestive, carotid artery stenosis, ejection fraction decreased, impaired healing, mitral valve calcification. Micronase dosage: 15 MG (15 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SIMVASTATIN, QUINAPRIL, AMLODIPINE BESYLATE, CETIRIZINE, CANDESARTAN CILEXETIL, FEXOFENADINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Micronase Side Effects Report #4602689-0
Micronase side effect was reported by a Physician from on Feb 22, 2005. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase. After drug was administered, patient experienced the following side effects: acute coronary syndrome, acute myocardial infarction, angiopathy, aortic valve incompetence, aortic valve sclerosis, blood pressure increased, cardiac failure congestive, cardiomegaly, carotid artery stenosis. Micronase dosage: 15 MG (15 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SIMVASTATIN, QUINAPRIL, AMLODIPINE BESYLATE, CETIRIZINE, CANDESARTAN CILEXETIL, FEXOFENADINE HYDROCHLORIDE. Patient recovered.

Micronase Side Effects Report #4634657-7
Micronase side effect was reported by a Physician from on Mar 31, 2005. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angiopathy, aortic valve incompetence, aortic valve sclerosis, blood pressure increased, cardiac failure congestive, cardiomegaly, carotid artery stenosis, chest discomfort. Micronase dosage: 15 MG (15 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SIMVASTATIN, QUINAPRIL, AMLODIPINE BESILATE, CETIRIZINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, FEXOFENADINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Micronase Side Effects Report #4811010-4
Micronase side effect was reported by a Physician from UNITED STATES on Oct 12, 2005. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase. After drug was administered, patient experienced the following side effects: acute coronary syndrome, acute myocardial infarction, aortic valve incompetence, aortic valve sclerosis, cardiac failure congestive, cardiomegaly, carotid artery stenosis, contrast media reaction, diastolic dysfunction. Micronase dosage: 15 MG (15 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ZOCOR, ACCUPRIL, NORVASC, ZYRTEC, CANDESARTAN CILEXETIL, ALLEGRA. Patient was hospitalized. Patient recovered.

Micronase Side Effects Report #4867146-5
Micronase side effect was reported by a Physician from UNITED STATES on Dec 12, 2005. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase. After drug was administered, patient experienced the following side effects: acute coronary syndrome, acute myocardial infarction, aortic valve incompetence, aortic valve sclerosis, cardiac failure congestive, cardiomegaly, carotid artery stenosis, chest x-ray abnormal, impaired healing. Micronase dosage: 15 MG (15 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MURAGLITAZAR, ZOCOR, ACCUPRIL, NORVASC, ZYRTEC, CANDESARTAN CILEXETIL, ALLEGRA. Patient was hospitalized. Patient recovered.